SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2312-2320

  Zhang, Junling ^a   Wang, Pengyuan ^a   Zhu, Jing ^a   Wang, Wei ^a   Yin, Jie ^a   Zhang, Chi ^b   Chen, Ziyi ^a   Sun, Lie ^a   Wan, Yuanlian ^a   Wang, Xin ^a   Chen, Guowei ^a   Liu, Yucun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Clonogenicity; Gastric cancer; Invasion; Proliferation; SPARC; VEGFR2

Indexed keywords

GELATINASE B; HERMES ANTIGEN; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN; CADHERIN; CD44 PROTEIN, HUMAN; CDH2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MMP7 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; SP1 PROTEIN, HUMAN; SPARC PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE ARREST; CLINICAL FEATURE; CLONOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; RANDOMIZATION; SECONDARY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

AGED; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CADHERINS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OSTEONECTIN; PROTO-ONCOGENE PROTEINS C-AKT; RANDOM ALLOCATION; SP1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84898616606     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3118     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010
3. Tai IT and Tang MJ: SPARC in cancer biology: Its role in cancer progression and potential for therapy. Drug Resist Updat 11: 231-246, 2008
4. Liang JF, Wang HK, Xiao H, et al: Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. J Exp Clin Cancer Res 29: 71, 2010
5. Atorrasagasti C, Malvicini M, Aquino JB, et al: Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells. Int J Cancer 126: 2726-2740, 2010
6. Chen G, Tian X, Liu Z, et al: Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: Modulation by FGFR1-III isoform expression. Br J Cancer 102: 188-195, 2010
7. Zhang JL, Chen GW, Liu YC, et al: Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer. PLoS One 7: E44618, 2012
8. Chlenski A and Cohn SL: Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol 21: 55-65, 2010
9. Nagaraju GP and El-Rayes BF: SPARC and DNA methylation: Possible diagnostic and therapeutic implications in gastrointestinal cancers. Cancer Lett 328: 10-17, 2013
10. Hasselaar P and Sage EH: SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49: 272-283, 1992
11. Funk SE and Sage EH: The Ca2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 88: 2648-2652, 1991
12. Said N and Motamed K: Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis. Am J Pathol 167: 1739-1752, 2005
13. Franke K, Carl-McGrath S, Röhl FW, et al: Differential expression of SPARC in intestinal-type gastric cancer correlates with tumor progression and nodal spread. Transl Oncol 2: 310-320, 2009
14. Wang L, Yang M, Shan L, et al: The role of SPARC protein expression in the progress of gastric cancer. Pathol Oncol Res 18: 697-702, 2012
15. Arnold SA and Brekken RA: SPARC: A matricellular regulator of tumorigenesis. J Cell Commun Signal 3: 255-273, 2009
16. Nagai MA, Gerhard R, Fregnani JH, et al: Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Breast Cancer Res Treat 126: 1-14, 2011
17. Liu YP and Hsiao M: Exercise-induced SPARC prevents tumorigenesis of colon cancer. Gut 62: 810-811, 2013
18. Yunker CK, Golembieski W, Lemke N, et al: SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer 122: 2735-2743, 2008
19. Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS and Lakka SS: The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. Br J Cancer 102: 530-540, 2010
20. Lau CP, Poon RT, Cheung ST, Yu WC and Fan ST: SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol 210: 459-468, 2006
21. Takeno A, Takemasa I, Doki Y, et al: Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer 99: 1307-1315, 2008
22. Junnila S, Kokkola A, Mizuguchi T, et al: Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer. Genes Chromosomes Cancer 49: 28-39, 2010
23. Wang CS, Lin KH, Chen SL, Chan YF and Hsueh S: Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Br J Cancer 91: 1924-1930, 2004
24. Chong HC, Tan CK, Huang RL and Tan NS: Matricellular proteins: A sticky affair with cancers. J Oncol 2012: 351089, 2012
25. Takaishi S, Okumura T, Tu S, et al: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020, 2009
26. Nieman MT, Prudoff RS, Johnson KR and Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-644, 1999